CD14 Facilitates Invasive Respiratory Tract Infection byStreptococcus pneumoniae (Q62516237)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

main subject

Streptococcus pneumoniae

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Mark C Dessing

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Sandrine Florquin

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Alex F de Vos

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Tom van der Poll

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

language of work or name

English

0 references

publication date

21 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Respiratory and Critical Care Medicine

23 December 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

175

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

604-611

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

Analogues of platelet activating factor. 4. Some modifications of the phosphocholine moiety

23 December 2019

cites work

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

The MyD88-dependent, but not the MyD88-independent, pathway of TLR4 signaling is important in clearing nontypeable haemophilus influenzae from the mouse lung

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

LPS, TLR4 and infectious disease diversity.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Antibodies against CD14 protect primates from endotoxin-induced shock

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Role of Toll-like receptor 4 in gram-positive and gram-negative pneumonia in mice.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Increased Circulating Soluble Cd14 Is Associated With High Mortality In Gram-Negative Septic Shock

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Cytokine immunotherapy during bacterial pneumonia: from benchtop to bedside

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Pneumonia models and innate immunity to respiratory bacterial pathogens

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Treatment with an anti-CD14 monoclonal antibody delays and inhibits lipopolysaccharide-induced gene expression in humans in vivo.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Transport of bacterial lipopolysaccharide to the golgi apparatus

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Double-stranded RNA-mediated TLR3 activation is enhanced by CD14.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Effect of anti-CD14 monoclonal antibody on clearance of Escherichia coli bacteremia and endotoxemia

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Release from a human monocyte-like cell line of two different soluble forms of the lipopolysaccharide receptor, CD14.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

CD14, new aspects of ligand and signal diversity

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Differing roles for platelet-activating factor during inflammation of the lung and subarachnoid space. The special case of Streptococcus pneumoniae.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Soluble lipopolysaccharide receptor (CD14) is released via two different mechanisms from human monocytes and CD14 transfectants.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Treatment of community-acquired pneumonia--IDSA guidelines. Infectious Diseases Society of America

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Innate recognition of lipopolysaccharide by Toll-like receptor 4-MD-2.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

CD14 deficiency leads to increased MIP-2 production, CXCR2 expression, neutrophil transmigration, and early death in pneumococcal infection.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Effect of CD14 blockade on endotoxin-induced acute lung injury in mice

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Differential Roles of CD14 and Toll-like Receptors 4and 2 in MurineAcinetobacterPneumonia

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Commentary on the 1993 American Thoracic Society guidelines for the treatment of community-acquired pneumonia

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Efficacy and safety of recombinant human activated protein C for severe sepsis

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14.

1 reference

27 May 2022

https://opencitations.net/index/coci/api/v1/references/10.1164/RCCM.200606-824OC

Identifiers

DOI

10.1164/RCCM.200606-824OC

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17185649%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference